Literature DB >> 17316927

Neurological adverse events temporally associated to mass vaccination against yellow fever in Juiz de Fora, Brazil, 1999-2005.

Guilherme Côrtes Fernandes1, Luiz Antonio Bastos Camacho, Marilia Sá Carvalho, Maristela Batista, Sonia Maria Rodrigues de Almeida.   

Abstract

The identification of adverse events following immunization (AEFI) and their prompt investigation are important to allow a timely and scientifically based response to the users of immunization services. This article presents an analysis of notified AEFI cases between 1999 and 2005 and their temporal association with 2001 yellow fever vaccination campaign, AEFI notification attributed to yellow fever vaccination rose from 0.06 to 1.32 per 100,000 vaccinees in Brazil, between 1998 and 2000. During the 2001 yellow fever mass vaccination campaign held in Juiz de Fora, Brazil, 12 cases of aseptic meningitis were temporally associated to yellow fever vaccination, but clinical and laboratory data were not available to confirm nor deny causality. Epidemiological studies associated to enhanced surveillance and standardized protocols should take advantage of public health interventions like mass vaccination campaigns and implementation of new vaccination strategies in order to assess and investigate vaccine safety.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17316927     DOI: 10.1016/j.vaccine.2007.01.078

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Longitudinal myelitis associated with yellow fever vaccination.

Authors:  M Chaves; P Riccio; L Patrucco; J I Rojas; E Cristiano
Journal:  J Neurovirol       Date:  2009-07       Impact factor: 2.643

Review 2.  Questions regarding the safety and duration of immunity following live yellow fever vaccination.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Expert Rev Vaccines       Date:  2016-06-20       Impact factor: 5.683

3.  Yellow fever control in Cameroon: where are we now and where are we going?

Authors:  Charles Shey Wiysonge; Emmanuel Nomo; Jeanne Mawo; James Ofal; Julienne Mimbouga; Johnson Ticha; Peter M Ndumbe
Journal:  BMC Med       Date:  2008-02-08       Impact factor: 8.775

4.  Use of electronic immunization registry in the surveillance of adverse events following immunization.

Authors:  Ana Paula Sayuri Sato; Vinícius Leati de Rossi Ferreira; Márcia de Cantuária Tauil; Laura Cunha Rodrigues; Mariana Bernardes Barros; Edmar Martineli; Ângela Aparecida Costa; Marta Inenami; Eliseu Alves Waldman
Journal:  Rev Saude Publica       Date:  2018-02-05       Impact factor: 2.106

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.